Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple Myeloma.

Xia LiAnne-Gaëlle DosneCarlos Pérez RuixoJuan Jose Perez Ruixo

Published in: Clinical pharmacokinetics (2023)

GOV : MMY1002 (ClinicalTrials.gov: NCT02116569), MMY1003 (NCT02852837), MMY1004 (NCT02519452), MMY1008 (NCT03242889), GEN501 (NCT00574288), MMY2002 (NCT01985126), MMY3012 (NCT03277105).

Keyphrases

multiple myeloma
emergency department
electronic health record
open label
drug induced